|
IP6K1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.53349996537366E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24879999674476E-08 |
| Normal-vs-Stage2 |
1.118770E-03 |
| Normal-vs-Stage3 |
2.020200E-03 |
| Normal-vs-Stage4 |
2.422500E-04 |
| Stage1-vs-Stage2 |
8.972200E-01 |
| Stage1-vs-Stage3 |
9.775000E-01 |
| Stage1-vs-Stage4 |
8.254200E-02 |
| Stage2-vs-Stage3 |
9.333400E-01 |
| Stage2-vs-Stage4 |
1.073980E-01 |
| Stage3-vs-Stage4 |
1.423380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.82140019417454E-10 |
| Normal-vs-AfricanAmerican |
1.045470E-04 |
| Normal-vs-Asian |
2.183200E-01 |
| Caucasian-vs-AfricanAmerican |
3.746600E-01 |
| Caucasian-vs-Asian |
7.583400E-01 |
| AfricanAmerican-vs-Asian |
6.312400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.26829674435203E-11 |
| Normal-vs-Female |
2.736400E-02 |
| Male-vs-Female |
4.322100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.79080000000309E-05 |
| Normal-vs-Extreme_Weight |
9.62130375370407E-11 |
| Normal-vs-Obese |
8.18420000000541E-05 |
| Normal-vs-Extreme_Obese |
3.620400E-02 |
| Normal_Weight-vs-Extreme_Weight |
5.413800E-01 |
| Normal_Weight-vs-Obese |
3.521800E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.708600E-01 |
| Extreme_Weight-vs-Obese |
6.065700E-02 |
| Extreme_Weight-vs-Extreme_Obese |
3.748600E-01 |
| Obese-vs-Extreme_Obese |
9.109200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.121200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.80170000000568E-05 |
| Normal-vs-Age(61-80Yrs) |
3.84250409268816E-11 |
| Normal-vs-Age(81-100Yrs) |
1.21150000031989E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.266200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.246000E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.598200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.589500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.810400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.808600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.06200000005163E-06 |
| Normal-VS-Type2 PRCC |
3.19389958924887E-10 |
| Normal-VS-KIRP CIMP |
7.031900E-02 |
| Normal-VS-Unclassified PRCC |
3.692200E-02 |
| Type1 PRCC-VS-Type2 PRCC |
3.061900E-03 |
| Type1 PRCC-VS-KIRP CIMP |
9.111600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.459400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.464200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.515810E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.030200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.83409986987249E-10 |
| Normal-vs-N1 |
5.85819999999737E-05 |
| Normal-vs-N2 |
1.310840E-01 |
| N0-vs-N1 |
9.691000E-01 |
| N0-vs-N2 |
9.752400E-01 |
| N1-vs-N2 |
9.921600E-01 |
|
|
